LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Cancer Solutions OncoSynergy is developing a novel class of cancer medicines aimed at improving patient survival and quality of life with minimal side effects, highlighting opportunities to collaborate with pharmaceutical companies seeking breakthrough oncology therapies.

Growing Clinical Pipeline Having launched its first clinical trial for glioblastoma in 2020 and expanding operations in Connecticut, OncoSynergy presents potential for partnerships in clinical research, drug development, and distribution within the oncology market.

Strategic Partnerships Recent collaborations with Infuseon Therapeutics and leadership ties to Moffitt Cancer Center suggest open avenues for co-development, joint research initiatives, and technology licensing in neuro-oncology and advanced treatment modalities.

Funding & Growth With $3.3 million in funding and a focus on expanding its team and infrastructure, OncoSynergy offers opportunities to investors or partners interested in early-stage biotech ventures with high-impact cancer therapies.

Niche Focus in Oncology Specializing in aggressive brain cancers like glioblastoma, OncoSynergy represents a targeted opportunity for organizations seeking to enter or expand within the high-growth neuro-oncology sector, especially in innovative, patient-centric treatment solutions.

OncoSynergy Tech Stack

OncoSynergy uses 8 technology products and services including Open Graph, MySQL, oEmbed, and more. Explore OncoSynergy's tech stack below.

  • Open Graph
    Content Management System
  • MySQL
    Database
  • oEmbed
    Dev Tools
  • Font Awesome
    Font Scripts
  • Google Fonts API
    Font Scripts
  • Modernizr
    Javascript Libraries
  • GoDaddy
    Web Hosting
  • Contact Form 7
    Web Platform Extensions

OncoSynergy's Email Address Formats

OncoSynergy uses at least 1 format(s):
OncoSynergy Email FormatsExamplePercentage
First@oncosynergy.comJohn@oncosynergy.com
50%
First@oncosynergy.comJohn@oncosynergy.com
50%

Frequently Asked Questions

Where is OncoSynergy's headquarters located?

Minus sign iconPlus sign iconOncoSynergy's main headquarters is located at Stamford, Connecticut 06902 United States. The company has employees across 1 continents, including North America.

What is OncoSynergy's phone number?

Minus sign iconPlus sign icon You can contact OncoSynergy's main corporate office by phone at
+1-415-666-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is OncoSynergy's official website and social media links?

Minus sign iconPlus sign iconOncoSynergy's official website is oncosynergy.com and has social profiles on LinkedInCrunchbase.

What is OncoSynergy's SIC code NAICS code?

Minus sign iconPlus sign iconOncoSynergy's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does OncoSynergy have currently?

Minus sign iconPlus sign iconAs of February 2026, OncoSynergy has approximately 4 employees across 1 continents, including North America. Key team members include Vp Of Corporate & Clinical Operations | Hr Manager: A. P.Co-Founder, Chief Executive Officer, Chief Medical Officer: A. C.Co-Founder, President Chief Executive Officer: L. H.. Explore OncoSynergy's employee directory with LeadIQ.

What industry does OncoSynergy belong to?

Minus sign iconPlus sign iconOncoSynergy operates in the Biotechnology Research industry.

What technology does OncoSynergy use?

Minus sign iconPlus sign iconOncoSynergy's tech stack includes Open GraphMySQLoEmbedFont AwesomeGoogle Fonts APIModernizrGoDaddyContact Form 7.

What is OncoSynergy's email format?

Minus sign iconPlus sign iconOncoSynergy's email format typically follows the pattern of First@oncosynergy.com. Find more OncoSynergy email formats with LeadIQ.

How much funding has OncoSynergy raised to date?

Minus sign iconPlus sign icon As of February 2026, OncoSynergy has raised $3.3M in funding. The last funding round occurred on Sep 08, 2020 for $3.3M.

When was OncoSynergy founded?

Minus sign iconPlus sign iconOncoSynergy was founded in 2011.

OncoSynergy

Biotechnology ResearchConnecticut, United States2-10 Employees

Our vision: "Cancer treatment in one dose." 

OncoSynergy is a patient-focused biotechnology startup spun out from UCSF and the JLABS South San Francisco incubator. Based in bustling Stamford, Connecticut (~40 mins from NYC), we are creating a new class of cancer medicines to maximize patient survival and quality of life with minimal side effects. We are a small, nimble startup team that launched our first clinical trial in 2020 for glioblastoma (aggressive brain cancer). 

While we are at the forefront of potential game changing research, please support our patients. They need you to spread awareness far and wide so that more research is being dedicated to devastating cancers like glioblastoma.

Section iconCompany Overview

Headquarters
Stamford, Connecticut 06902 United States
Phone number
+1-415-666-****
Website
oncosynergy.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2011
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $3.3M

    OncoSynergy has raised a total of $3.3M of funding over 2 rounds. Their latest funding round was raised on Sep 08, 2020 in the amount of $3.3M.

  • $1M

    OncoSynergy's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $3.3M

    OncoSynergy has raised a total of $3.3M of funding over 2 rounds. Their latest funding round was raised on Sep 08, 2020 in the amount of $3.3M.

  • $1M

    OncoSynergy's revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    A. P.
    Vp Of Corporate & Clinical Operations | Hr Manager
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. C.
    Co-Founder, Chief Executive Officer, Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. H.
    Co-Founder, President Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. N.
    Clinicaltranslational Research Associate
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.